4.4 Review

Role of the Transcriptional Repressor BCL6 in Allergic Response and Inflammation

Journal

WORLD ALLERGY ORGANIZATION JOURNAL
Volume 1, Issue -, Pages 115-122

Publisher

BIOMED CENTRAL LTD
DOI: 10.1097/WOX.0b013e31817dc522

Keywords

allergy; BCL6; cytokine; chemokine; lgE; Th2; transcriptional repressor

Ask authors/readers for more resources

Various molecules participate in different phases of allergic reactions. This means that many genes are encoding molecules related to allergic reactions, such as cytokines, chemokines, and their receptors as effector molecules. The transcriptional repressor BCL6 has emerged as a multifunctional regulator of lymphocyte differentiation and immune responses. BCL6-deficient (BCL6(-/-)) mice display T helper type 2 (Th2) Ytype inflammation, which is caused by abnormality of both lymphoid cells and nonlymphoid cells. Thus, BCL6 apparently contributes to negative regulation of various central molecules such as cytokines, in particular Th2 cytokines, CC chemokines, and immunoglobulin E in allergic diseases. Therefore, BCL6 may be a molecular target for Th2-type allergic diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available